[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366881-105":59,"doc-detail-366881-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteoglycans-in-prostate-cancer-progression-and-therapy-resistance-narrative-review","Proteoglycans in Prostate Cancer Progression and Therapy Resistance - narrative review","","The extracellular matrix (ECM) forms a complex noncellular network that supports diverse cells within tissues and organs. In cancer, ECM becomes part of the tumor microenvironment (TME), embedding cancer cells and stromal components such as fibroblasts, endothelial and immune cells. Proteoglycans (PGs), core ECM components built from a protein core and glycosaminoglycan chains, are involved in key processes through their structural diversity. In prostate cancer, PGs influence tumor progression and therapy resistance, including tumor-promoting members (versican, perlecan, biglycan) and tumor-suppressive members (decorin, betaglycan), while syndecan 1 shows context-dependent effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteoglycans-in-prostate-cancer-progression-and-therapy-resistance-narrative-review/366881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteoglycans-in-prostate-cancer-progression-and-therapy-resistance-narrative-review/366881.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do proteoglycans play in the tumor microenvironment?","Question",{"text":112,"@type":113},"Proteoglycans are core components of the extracellular matrix that contributes to the tumor microenvironment. They are involved in multiple interactions and processes that support cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which proteoglycans are described as tumor-promoting versus tumor-suppressive in prostate cancer?",{"text":117,"@type":113},"The text highlights versican, perlecan, and biglycan as tumor-promoting. Decorin and betaglycan are described as tumor-suppressive.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the search strategy for the narrative review conducted?",{"text":121,"@type":113},"The PubMed database was searched using terms combining proteoglycan, prostate, and cancer, including major core matrisome proteoglycans. Emphasis was placed on more recent studies (within the last ten years), with priority given to human-subject data, while in vitro-only studies were also considered.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366881,1790852582,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nProteoglycans in Prostate Cancer Progression and Therapy Resistance  \nIvana Samaržija   \nAcademic Editor: Giuseppe Lucarelli  \nReceived: 27 September 2025  \nRevised: 19 November 2025  \nAccepted: 24 November 2025  \nPublished: 27 November 2025  \nCitation: Samaržija, I. Proteoglycans in Prostate Cancer Progression and Therapy Resistance. Medicina 2025, 61, 2112. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)medicina61122112  \nCopyright: © 2025 by the author. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nLaboratory for Epigenomics, Division of Molecular Medicine, Ruer Boškovi´c Institute, 10000 Zagreb, Croatia; [ivana.samarzija@irb.hr](ivana.samarzija@irb.hr)  \nAbstract  \nThe extracellular matrix (ECM) is a complex noncellular network of (macro-)molecules that surrounds and supports diverse cells in tissues and organs. In cancer, ECM is a part of the tumor microenvironment (TME) that embeds its cellular components including cancer cells and the neighboring non-cancerous stromal cells such as fibroblasts, endothelial, and immune cells. Given the complexity of players and interactions that the ECM participatesin and is exposed to in the TME, it does not come as a surprise that many of the processes that drive cancer progression take part precisely in the ECM compartment of the TME. Along with diverse glycoproteins and collagens, proteoglycans (PGs) are among the main components of the core ECM. PGs are composed of a protein core to which glycosaminoglycan chains are attached. Considering the structural diversity of these molecules and their ‘hybrid’ nature, it is not surprising that they are involved in a variety of processes that are vital for surrounding cells. Moreover, they are secreted by both cancer and stromal cells, contributing to the complexity of interactions in the TME. In prostate cancer, PGshave been shown to be involved in many steps of its progression; the most prominent examples include the seemingly tumor-promoting roles of versican, perlecan, and biglycan, and the tumor-suppressive roles of decorin and betaglycan. The role of syndecan 1 is a bit more complex; namely, the nature of its role is context dependent. In this narrative review article, the roles of PGs in prostate cancer progression and therapy resistance are discussed in more detail.  \nKeywords: proteoglycan; prostate cancer; cancer progression; therapy resistance; biomarker; extracellular matrix; tumor microenvironment  \n1. Introduction  \nThe tumor microenvironment (TME) is a collective name for components found in tissue surrounding tumors; it is composed of cancer cells and the neighboring noncancerous stromal cells such as fibroblasts, endothelial, and immune cells [1] . The cellular components of the TME are embedded in the extracellular matrix (ECM), a complex network of (macro-)molecules that surrounds and supports diverse cells in tissues and organs [2,3] . The increasing knowledge on the importance of the TME in cancer progression has led to recognition that most of the hallmarks of cancer are enabled and sustained by TME components [4,5] . Since ECM is a vital part of the TME, it does not come as a surprise that it is involved actively in many steps of tumor progression [6,7] .  \nAlong with many glycoproteins and collagens, proteoglycans (PGs) are among the main components of the core ECM. PGs show ‘hybrid’ nature, that is, they are composed  \nof a protein core to which glycosaminoglycan chains are attached. Their diverse structure enables numerous interactions and participation in a multitude of processes which are, in particular, widely studied in reference to different","cbCaibNF6P9ven95","https://ap.wps.com/l/cbCaibNF6P9ven95","pdf",840859,24,"English","# Abstract\n# 1. Introduction\n# 2. Proteoglycans\n# Search Strategy and Selection Criteria","[{\"question\":\"What role do proteoglycans play in the tumor microenvironment?\",\"answer\":\"Proteoglycans are core components of the extracellular matrix that contributes to the tumor microenvironment. They are involved in multiple interactions and processes that support cancer progression.\"},{\"question\":\"Which proteoglycans are described as tumor-promoting versus tumor-suppressive in prostate cancer?\",\"answer\":\"The text highlights versican, perlecan, and biglycan as tumor-promoting. Decorin and betaglycan are described as tumor-suppressive.\"},{\"question\":\"How is the search strategy for the narrative review conducted?\",\"answer\":\"The PubMed database was searched using terms combining proteoglycan, prostate, and cancer, including major core matrisome proteoglycans. Emphasis was placed on more recent studies (within the last ten years), with priority given to human-subject data, while in vitro-only studies were also considered.\"}]","Proteoglycans in Prostate Cancer Progression and Therapy Resistance - narrative review | PDF",1790168108,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34464d2b57d6d1675c8ef44d60875bec.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b4a6dc9932f2c89b469083fe94caf55.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d34ece2556200cb875cbc3e8c73552fd.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18771e70b5bb12f15aff7cd83592e1ae.webp",980,1385]